Hispanic Broadcasting Newswire

Comprehensive Real-Time News Feed for Hispanic Broadcasting.

Results 1 - 20 of 123 in Hispanic Broadcasting

  1. Hospira CFO Unloads $515,000 in StockRead the original story

    Wednesday Jul 16 | AmericanBankingNews.com

    Hospira CFO Thomas E. Werner sold 10,000 shares of the company's stock in a transaction dated Tuesday, July 15th.

    Comment?

  2. Acceleron Pharma Appoints Terrence C. Kearney to its Board of Directors [Global Data Point]Read the original story

    Tuesday Jul 15 | Customer Interaction Solutions

    "Terry brings significant industry experience, corporate leadership and financial expertise to Acceleron and we feel he will be a valuable contributor to our board," said John Knopf, Ph.D., Chief Executive Officer of Acceleron.

    Comment?

  3. Hospira Lactated Ringer's and 5% Dextrose Injection Recalled:...Read the original story w/Photo

    Monday Jul 14 | PRWeb

    On July 11, the FDA informed that one lot of Lactated Ringers and 5% Dextrose Injection, USP, 1000 mL, Flexible Container, by Hospira Inc., is recalled due to mold contamination.

    Comment?

  4. Acceleron Pharma Appoints Terrence C. Kearney to its Board of DirectorsRead the original story

    Monday Jul 14 | Customer Interaction Solutions

    Acceleron Pharma Inc. , a biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today announced the appointment of Terrence C. Kearney to its Board of Directors and to the position of Chair of the Audit Committee.

    Comment?

  5. Hospira Lactated Ringer's And 5% Dextrose Injection, 1000 ML,...Read the original story

    Thursday Jul 10 | Drugs.com

    ISSUE: Hospira, Inc. announced it is initiating a voluntary nationwide user-level recall of one lot of Lactated Ringers and 5% Dextrose Injection, USP, 1000 mL, Flexible Container, NDC 0409-7929-09, Lot 35-118-JT, Expiry 1NOV2015 .

    Comment?

  6. Hospira Issues Voluntary Nationwide Recall Of One Lot Of Lactated...Read the original story

    Friday Jul 11 | US Food and Drug Administration

    FDA posts press releases and other notices of recalls and market withdrawals from the firms involved as a service to consumers, the media, and other interested parties.

    Comment?

  7. Hospira Recalls Dextrose with Lactated Ringer Injection, Expands Heparin RecallRead the original story

    Friday Jul 11 | ASHP

    Hospira Inc. on Thursday announced the recall of lot 35-118-JT of the company's 1000-mL 5% dextrose with lactated Ringer injection because a filamentous particulate in the solution of one primary container looked like mold.

    Comment?

  8. Hospira, Inc. Completes Acquisition Of Orchid Chemicals &...Read the original story

    Monday Jul 7 | BioSpace

    "We're committed to the antibiotics space, and with our new colleagues from Orchid, we will continue to bring high-quality, lower-cost products to patients around the world."

    Comment?

  9. Hospira acquires API manufacturing and R&D facilities from Orchid for about $218 millionRead the original story w/Photo

    Monday Jul 7 | Medical News

    Hospira, Inc. , the world's leading provider of injectable drugs and infusion technologies, today announced it has completed the acquisition of an active pharmaceutical ingredient manufacturing facility and an associated research and development facility from Orchid Chemicals & Pharmaceuticals Ltd. , a leading Indian pharmaceuticals company, for ... (more)

    Comment?

  10. Hospira Completes Acquisition of Orchid's Active Pharmaceutical...Read the original story

    Friday Jul 4 | Freshnews

    Hospira, Inc. , the world's leading provider of injectable drugs and infusion technologies, today announced it has completed the acquisition of an active pharmaceutical ingredient manufacturing facility and an associated research and development facility from Orchid Chemicals & Pharmaceuticals Ltd. , a leading Indian pharmaceuticals company, for ... (more)

    Comment?

  11. Hospira, Inc. To Host Conference Call For Second-Quarter 2014 ResultsRead the original story

    Wednesday Jul 2 | BioSpace

    A live webcast of the conference call and related material will be available on Hospira's website at www.hospirainvestor.com .

    Comment?

  12. Hospira to Host Conference Call for Second-Quarter 2014 ResultsRead the original story

    Tuesday Jul 1 | Freshnews

    Hospira, Inc. , the world's leading provider of injectable drugs and infusion technologies, will host a conference call to discuss its second-quarter 2014 results on Wednesday, July 30, 2014 at 8 a.m. Central time.

    Comment?

  13. NIRI-Chicago Elects 2014-2015 Officers and DirectorsRead the original story

    Jun 20, 2014 | Business Wire

    The Chicago Chapter of the National Investor Relations Institute has elected 14 officers and directors to its board for the 2014-2015 term.

    Comment?

  14. NIRI-Chicago Elects 2014-2015 Officers and DirectorsRead the original story

    Jun 20, 2014 | Business Wire

    The Chicago Chapter of the National Investor Relations Institute has elected 14 officers and directors to its board for the 2014-2015 term.

    Comment?

  15. Cubist has an Fda Pdufa Date for Tedizolid Phosphate (TR-701) of June 20, 2014Read the original story

    Jun 6, 2014 | Theflyonthewall.com

    On The Fly: After Hours Movers HIGHER: Family Dollar , up 2.58% after Carl Icahn sent a letter to CEO urging an immediate sale... Cubist , up 1.68% after the FDA accepted the company's NDA for its investigational antibiotic ceftolozane/tazobactam with Priority Review.

    Comment?

  16. Cubist announces acceptance of Ceftolozane/Tazobactam NDA Priority ReviewRead the original story

    Jun 5, 2014 | Theflyonthewall.com

    Hospira granted tentative approval for generic daptomycin Hospira was granted tentative approval for generic daptomycin, according to a post to the FDA's website dated June 16. Daptomycin is an antibiotic used in the treatment of infections caused by Gram-positive organisms that is sold under the trade name Cubicin by Cubist Pharmaceuticals .

    Comment?

  17. High option volume stocks:Read the original story

    Jun 5, 2014 | Theflyonthewall.com

    Hospira granted tentative approval for generic daptomycin Hospira was granted tentative approval for generic daptomycin, according to a post to the FDA's website dated June 16. Daptomycin is an antibiotic used in the treatment of infections caused by Gram-positive organisms that is sold under the trade name Cubicin by Cubist Pharmaceuticals .

    Comment?

  18. Hospira Announces Voluntary Nationwide Recall Of 0.5% MarcaineaRead the original story w/Photo

    Jun 18, 2014 | Pharmaceutical Processing

    Hospira, Inc. , announced it will initiate a voluntary nationwide recall to the user level for one lot of 0.5% Marcainea , 30 mL, Single-dose Vial - Preservative Free , Lot 33-545-DD.

    Comment?

  19. Hospira Issues Recall Due to Visible Particulates in VialsRead the original story

    Jun 18, 2014 | Pharmaceutical Technology

    On June 17, Hospira, Inc. announced a voluntary nationwide recall to the user level for one lot of 0.5% Marcaine , 30 mL, Single-dose Vial - Preservative Free , Lot 33-545-DD.

    Comment?

  20. Hospira, Inc. Announces Voluntary Nationwide Recall Of One Lot Of...Read the original story

    Jun 18, 2014 | BioSpace

    Hospira, Inc. Announces Voluntary Nationwide Recall Of One Lot Of 0.5% Marcaine , 30 ML, Single-Dose, Preservative-Free Vial Due To Visible Particulates Hospira, Inc. Announces Voluntary Nationwide Recall Of One Lot Of 0.5% Marcaine , 30 ML, Single-Dose, Preservative-Free Vial Due To Visible Particulates FOR IMMEDIATE RELEASE - June 17, 2014 - ... (more)

    Comment?